Microbes are well-known among biologists as master engineers of useful small molecules, and there are many tricks of their trade. When researchers at the University of Illinois took a closer look at how a known microbe makes a known so-called natural product, they were rewarded with the discovery of a completely unknown biochemical trick.
John A. Moran Eye Center physician-researcher Paul S. Bernstein, MD, PhD, and his patients at the University of Utah played a key role in the recent discovery of the first genetic cause for a rare eye disease.
Recombinant Human Growth Hormone (rhGH) preparations have been approved for use in children with Prader-Willi syndrome at the US FDA in 2000 and EMA in 2001. However, systematic studies of the treatment of infants and children under 2 years of age with this drug were not enough. Korean scientists have done new research and found that growth hormone treatment improves the growth and body composition of patients with Prader-Willi syndrome.
People suffering from insomnia may have an increased risk of coronary artery disease, heart failure and stroke, according to new research in the American Heart Association's journal Circulation.
Researchers at Western University have developed a new way to deliver the DNA-editing tool CRISPR-Cas9 into microorganisms in the lab, providing a way to efficiently launch a targeted attack on specific bacteria.
San Francisco Bay Area startup BillionToOne is getting ready to launch a prenatal genetic screening test that combines maternal carrier screening for five single-gene recessive disorders with a reflex noninvasive prenatal test (NIPT) of the fetus.
